Found 347 matching trials
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer N/A This is a feasibility study evaluating the use of a mathematical model to p...
Show More Location
University of New Mexico Comprehensive Cancer Center
Learn More & Join Trial
CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer(Cinnamon) PHASE3 This study is a Phase III non-inferiority trial targeting a specific subset...
Show More Location
Multiple Locations
Learn More & Join Trial
Adj TC + Herceptin Early Stage Breast Cancer PHASE2 The purpose of this research study is to find out what effects (good and ba...
Show More Location
Birmingham Hematology and Oncology
Learn More & Join Trial
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer PHASE2 Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer PHASE2 Triple-negative breast cancer (TNBC) is a special type of breast cancer, en...
Show More Location
Guangdong general hospital
Learn More & Join Trial
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer PHASE2 This multi-center, open-label, phase II randomized controlled trial is to e...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients PHASE2 A multicenter, prospective, open, randomized cohort, non controlled phase I...
Show More Learn More & Join Trial
DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer PHASE2 Our study is a prospective, non-inferior, randomized phase II clinical tria...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients PHASE2 Sinonasal tumors are rare diseases, as they account for the 0.2 % - 0.8 % o...
Show More Location
Presidio Ospedaliero Spedali Civili di Brescia
Learn More & Join Trial